Authors reported that some pharmacological agents possess neuroprotective effect due to their ability to block NF-κB activation, suggesting its pro-apoptotic role in PD [55,56,57], thus being a possible target to counteract neurodegenerative diseases. Here, NFKB1 is linked to Parkinson disease.